U.S. Senators Tammy Baldwin and Elizabeth Warren Lead Bipartisan Call on FDA to End Discriminatory Blood Donation Ban
In light of the tragic mass shooting in Orlando, 24 Senators join letter urging FDA to develop better blood donation policies based on individual risk
WASHINGTON, D.C. — U.S. Senators Tammy Baldwin (D-WI) and Elizabeth Warren (D-MA) today led a bipartisan group of 24 Senators in calling on the Food and Drug Administration (FDA) to swiftly move to end the discriminatory blood donation deferral policy for men who have sex with men (MSM). The bipartisan letter was sent in light of the recent mass shooting at Pulse nightclub in Orlando, Florida, and requests an update on FDA’s efforts to implement the updated one year deferral policy and to completely end the blood ban by developing better blood donor deferral policies that are grounded in science, based on individual risk factors, don’t unfairly single out one group of individuals, and allow all healthy Americans to donate.
“During times of tragedy, the American people are quick to demonstrate their resiliency and mobilize in solidarity with victims and affected communities. We have witnessed that compassion as Floridians quickly lined up to donate blood for the wounded. Yet, some of those most touched by this tragedy—members of the LGBT community, who are especially eager to contribute to the response effort—are finding themselves turned away. Due to the FDA’s current MSM deferral policy, many healthy gay and bisexual men remain prohibited from donating needed blood,” the senators wrote. “We are steadfastly committed to ending the FDA’s discriminatory policy that prohibits many healthy MSM from donating blood and moving to policies that secure our nation’s blood supply in a scientifically sound manner based on individual risk.”
At the end of last year, the FDA released guidance that lifted the lifetime ban on blood donation and implemented a new policy requiring a year of abstinence prior to donating blood. While the Senators express support for this step forward, they maintain that a time-based deferral not based on individual risk remains discriminatory. In December 2014, over 75 members of Congress in called on HHS Secretary Burwell to end the outdated and discriminatory ban, and replace it by instituting a risk-based policy.
A copy of the letter is available online here.
Press Releases by Tammy Baldwin
U.S. Senator Tammy Baldwin Announces $1.5 Million to Expand Apprenticeship Opportunities Across WisconsinOct 21st, 2016 by Tammy Baldwin
“Apprenticeship initiatives are one of the most effective vehicles for responding to the workforce readiness needs of business and industry,” said Senator Baldwin.
U.S. Senator Tammy Baldwin Calls on Wisconsin Attorney General Brad Schimel to Get the Job Done on Wisconsin’s Longstanding Rape Kit BacklogOct 5th, 2016 by Tammy Baldwin
More than one year after Wisconsin Justice Department received federal investments, reports show state still has 6,000 kit backlog
U.S. Senator Tammy Baldwin Statement on Investigations into Madison and Milwaukee Social Security OfficesSep 21st, 2016 by Tammy Baldwin
For the past year, Baldwin has worked on behalf of whistleblowers and raised questions about wrongdoing, harassment and retaliation
U.S. Senator Tammy Baldwin Pushes for Economic Growth in Wisconsin with Small Business Innovation ActSep 21st, 2016 by Tammy Baldwin
National reform will support Wisconsin, which ranks last nationally in startup activity and entrepreneurship growth
We Must Do More to Provide Debt Relief & Support to Students, Veterans Suffering from Wide-Ranging Impacts of ITT Tech ClosureSep 17th, 2016 by Tammy Baldwin
Senators now call on ED to “use its existing legal authority” to increase total debt relief and support available to former ITT Tech students
Baldwin, McCain, Schakowsky Introduce Reform Requiring Transparency in Prescription Drug Price IncreasesSep 15th, 2016 by Tammy Baldwin
The bipartisan and bicameral FAIR Drug Pricing Act takes the first step to address skyrocketing prescription drug costs